Company · Healthtech & Bio

Medicsen

medicsen.com ↗ ·Madrid ·Seed

Medicsen is a Madrid-based healthtech/medtech company developing the Smartpatch, a needle-free wearable drug delivery device that uses sonophoresis (ultrasound waves) to temporarily increase skin permeability and painlessly deliver large molecules such as insulin and heparin through the skin. Founded in 2015 by doctors Eduardo W. Jorgensen and Patricia Cremades with telecom engineers César de Mercado and José Carlos Montesinos, it started with a glucose-prediction app and AI-driven insulin delivery before focusing on the transdermal patch. Funding has been largely non-dilutive: around €5M secured in 2024 through the EU EIC Accelerator, Innovate UK Smart Grants and the Spanish Ministry of Science/CDTI, with an EIC equity component expected; no traditional VC fund is an equity investor.

Founded
2015
Founders
4
News
0
Rounds
1
Investors
7
SectorsHealthtech, Medical Devices, Drug Delivery, Diabetes Care, Deeptech, Wearables Start-up MapHealthtech & Bio › Medical devices & surgical hardware

Profile updated 4 Sep 2026

Founders

César de Mercado
COO & Co-Founder
Eduardo W. Jørgensen de Vizcarrondo
CEO & Co-Founder
José Carlos Montesinos Pérez
CTO & Co-Founder
Patricia Cremades
Medical Co-Founder
—

Global models

No comparables on record yet.

Investors 7

Brisbane Economic Development Agency
Investor Australia
CDTI (Centro para el Desarrollo Tecnológico Industrial)
www.cdti.es
Investor Spain
EIC Accelerator (European Innovation Council)
eic.ec.europa.eu
Investor Luxembourg
Investor United Kingdom
Ministerio de Ciencia, Innovación y Universidades (Spain)
Investor Spain
South Summit
Investor Spain
SpinLab – The HHL Accelerator
Investor Germany

Funding rounds 1

Other · €5M
Medicsen announced €5M of non-dilutive funding — not an equity round — secured through four public instruments: Innovate UK 'Smart' and 'Nee…
2024-04-29

News & media

No coverage on record yet.
Start typing to search across everything.
↑↓ navigate↵ openesc close